International audienceBACKGROUND: Thirty percent of Covid-19 patients admitted to intensive care units present with thrombotic complications despite thromboprophylaxis. Bed resting, obesity, hypoxia, coagulopathy, acute excessive inflammation are potential mechanisms reported by previous studies. Better understanding of the underlying mechanisms leading to thrombosis is crucial for developing more appropriate prophylaxis and treatment strategies. OBJECTIVE: We aimed to assess fibrinolytic activity and thrombin generation in 78 Covid-19 patients. PATIENTS AND METHODS: Forty eight patients admitted to intensive care unit (ICU) and 30 patients admitted to the internal medicine department were included in the study. All patients received thromb...
BackgroundCOVID-19 associated coagulopathy (CAC) is associated with an increase in thromboembolic ev...
Objective COVID 19 is often associated with hypercoagulability and thromboembolic (TE) events. The a...
In late December 2019 an outbreak of a novel coronavirus (SARS-CoV-2) causing severe pneumonia (COVI...
International audienceBACKGROUND: Thirty percent of Covid-19 patients admitted to intensive care uni...
Background Coagulation abnormalities in COVID-19 patients have not been addressed in depth. Objecti...
We read with much interest the recent observational study of Nougier et al., which aimed at studying...
Background: There is emerging evidence for enhanced blood coagulation in coronavirus 2019 (COVID-19)...
We read with much interest the recent observational study of Nougier et al., which aimed at studying...
Background and Aims: Patients with severe coronavirus disease 2019 (COVID-19) are at significant ris...
INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection is associated wi...
High rates of thrombosis are present in patients with severe acute respiratory syndrome coronavirus ...
International audiencePURPOSE:Little evidence of increased thrombotic risk is available in COVID-19 ...
Background: The prothrombotic phenotype has been extensively described in patients with acute corona...
Background Severe COVID-19 disease is associated with thrombotic complications and extensive fibrin ...
BackgroundCOVID-19 associated coagulopathy (CAC) is associated with an increase in thromboembolic ev...
Objective COVID 19 is often associated with hypercoagulability and thromboembolic (TE) events. The a...
In late December 2019 an outbreak of a novel coronavirus (SARS-CoV-2) causing severe pneumonia (COVI...
International audienceBACKGROUND: Thirty percent of Covid-19 patients admitted to intensive care uni...
Background Coagulation abnormalities in COVID-19 patients have not been addressed in depth. Objecti...
We read with much interest the recent observational study of Nougier et al., which aimed at studying...
Background: There is emerging evidence for enhanced blood coagulation in coronavirus 2019 (COVID-19)...
We read with much interest the recent observational study of Nougier et al., which aimed at studying...
Background and Aims: Patients with severe coronavirus disease 2019 (COVID-19) are at significant ris...
INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection is associated wi...
High rates of thrombosis are present in patients with severe acute respiratory syndrome coronavirus ...
International audiencePURPOSE:Little evidence of increased thrombotic risk is available in COVID-19 ...
Background: The prothrombotic phenotype has been extensively described in patients with acute corona...
Background Severe COVID-19 disease is associated with thrombotic complications and extensive fibrin ...
BackgroundCOVID-19 associated coagulopathy (CAC) is associated with an increase in thromboembolic ev...
Objective COVID 19 is often associated with hypercoagulability and thromboembolic (TE) events. The a...
In late December 2019 an outbreak of a novel coronavirus (SARS-CoV-2) causing severe pneumonia (COVI...